IL-10 Agonist Paired With Anti-PD-1 Shows Promise in Lung, Kidney Cancer

03 Oct 2019

·www.bioportfolio.com

(MedPage Today) -- Added pegilodecakin to nivolumab or pembrolizumab yielded high activity in IVY study

Organizations

Indications

Targets

IL-10PD-1

Drugs

PEG-ilodecakinNivolumabPembrolizumab

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.